The global mobile cardiac telemetry system market size surpassed USD 1,181 million in 2024 and is predicted to reach around USD 2,646 million by 2034, registering a CAGR of 8.4% from 2024 to 2034.
Mobile cardiac telemetry (MCT) equipment is sophisticated ambulatory device intended for tracking the patient’s cardiac function in real-time. These systems include body-worn sensors, stickers or patches with attached electrodes, and a handheld recorder for capturing and transmitting instantaneous ECG signals to a central hub or attending doctor.
With the increasing prevalence of cardiovascular disorders and the resulting deaths on the rise, awareness concerning the advantages related to MCT devices is rising, thus driving the mobile cardiac telemetry systems market. The rising incidence rate of arrhythmia is acknowledged as one of the key drivers that shape the demand for a mobile cardiac telemetry system. Meanwhile, the Centers for Disease Control and Prevention (CDC) has estimated that 12.1 million people will have atrial fibrillation (AFib), which is a type of heart arrhythmia in 2030.
The increase in the usage of MCT devices largely due to senior people and heart patients increases the accessibility of healthcare services. This is evident by strict measures governing the technological product, and well-established mobile cardiac telemetry systems manufacturers exist in the United States hence being able to confirm productivity and efficiency, with a special focus on patient safety.
Published by Ajit Bansod
